MicroPort Endovascular MedTech's Fiber Wool Plug Spring Coil Gains NMPA Marketing Approval
CompanyMedical Device

MicroPort Endovascular MedTech’s Fiber Wool Plug Spring Coil Gains NMPA Marketing Approval

NMPA unveils 83rd GQCE reference drug batch
Policy / Regulatory

NMPA Expands Generic Quality Consistency Evaluation with 83rd Batch of Reference Drugs

Kailera Therapeutics Emerges with USD 400 Million in Series A Funding for Anti-Obesity Pipeline
CompanyDeals

Kailera Therapeutics Emerges with USD 400 Million in Series A Funding for Anti-Obesity Pipeline

AstraZeneca Strikes Exclusive Licensing Deal with CSPC Pharma for Oral Lp(a) Disruptor
CompanyDeals

AstraZeneca Strikes Exclusive Licensing Deal with CSPC Pharma for Oral Lp(a) Disruptor

Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment
CompanyDeals

Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment

MediLink Therapeutics Partners with Amgen for Clinical Trial in Small Cell Lung Cancer
CompanyDeals

MediLink Therapeutics Partners with Amgen for Clinical Trial in Small Cell Lung Cancer

Cassava Sciences to Pay Over USD 40 Million to Settle SEC Charges Over Alzheimer’s Drug Claims
Company

Cassava Sciences to Pay Over USD 40 Million to Settle SEC Charges Over Alzheimer’s Drug Claims

Wuhan YZY Biopharma Grants Rights to CD3/EpCAM Antibody M701 to Chi Ta TianQing Pharma in China
CompanyDeals

Wuhan YZY Biopharma Grants Rights to CD3/EpCAM Antibody M701 to Chi Ta TianQing Pharma in China

Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront
CompanyDeals

Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront

China's CDE Announces "Care Plan" to Include Pfizer's Marstaximab for Rare Disease Drug Development
CompanyDrug

China’s CDE Announces “Care Plan” to Include Pfizer’s Marstaximab for Rare Disease Drug Development

Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies
CompanyDeals

Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies

WuXi AppTec and WuXi Biologics Weigh Asset Sales in US and Europe Over Biosecure Act Concerns
Company

WuXi AppTec and WuXi Biologics Weigh Asset Sales in US and Europe Over Biosecure Act Concerns